The Government of Goa, in association with Novo Nordisk Education Foundation (NNEF), launched India’s first Diabetes Registry that will help health service departments in the state to monitor the metabolic disease on a regular basis. The registry will aim to capture details of every individual Diabetes patient in the state and will further aid government health services to monitor each patient based on a unique identification number. In a first of its kind effort by the any state in India, the Diabetes registry will aid the government in a population based approach to risk assessment and thereby aid in better and effective management of various chronic diseases related to the alarming increase of Diabetes.
The registry was launched by Goa Chief Minister Digambar Kamat at Kala Academy in Panjim, Goa on Friday. Speaking on the occasion, Kamat said, “Diabetes is emerging to be one of the most serious health problems of our time. It is imperative that we create a conducive environment to tackle this growing problem. ”We strongly believe that the launch of this registry will augment our effort in reaching out to thousands of people in Goa and thereby make a significant impact in the way Diabetes is perceived, treated and managed in the state.”
Ambassador of Denmark to India, Freddy Svane said, “In a fast growing and vibrant economy like India, Diabetes and its complications can lead to huge human and economic loss. The initiatives undertaken by the Goa government to tackle diabetes, including the launch today of the first Diabetes registry by a state in India, are commendable. ”I am keen to ensure even closer cooperation between Danish and Indian organizations in order to facilitate access to quality healthcare in India”.
Addressing the gathering, Minister for Health Vishwajit Rane said, “There is a need to create awareness and educate people about Diabetes. It is important for all concerned parties to get together in delivering Diabetes awareness, screening, education and treatment to the common man. The registry is a crucial step towards bridging this fundamental gap.”
As part of the state-wide campaign – ‘Changing Diabetes Barometer’ – launched by the State Government and NNEF in Aug 2008, the registry will help identify people at risk of diabetic complications and aid in reducing the gap between evidence-based recommendations for care and clinical outcomes. This date will further be utilized as a critical feature for population-based disease management.
In India, where we have over 50.8 million people who are Diabetes, the economic cost of Diabetes is estimated to be 2.1% of the GDP.
The cost of Diabetes includes lost productivity and the cost of treating the disease and its complications, such as heart disease, hypertension, and diabetic retinopathy. In fact the Government will also be formulating a policy to extend free treatment & medication for Diabetes to all Goans. This is also increasingly acknowledged to be a unique initiative that could be replicated across India in a country which has the highest population in Diabetes.
“We, at Novo Nordisk are happy to partner with the Goa government in creating awareness at a mass level. This will be a result oriented programme that will bring greater number of people to systematic screening, diagnostic and treatment process for Diabetes This will also lead to better outcomes as well as rein in the rising prevalence of Diabetes”, said Melvin D’souza, Managing Trustee, Novo Nordisk Education Foundation.Novo Nordisk Education Foundation is a non-profit organization created in 1998 with the purpose of increasing diabetes awareness. Today, an estimated 230 million people, almost 6% of the world’s adult population has diabetes. This number is expected to grow to 380 million by 2025,according to International Diabetes Federation (IDF). Diabetes is a chronic condition that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. There are two basic forms of diabetes: type 1 and type 2. People with type 1 diabetes produce very little or no insulin. People with type 2 diabetes cannot use insulin effectively. The majority of people with diabetes have type 2.